Efficacy and safety of short-term 1-3 months versus standard 12 months dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized clinical trials.
In conclusion, the short-term DAPT can reduce the risk of bleeding compared with standard DAPT, without increasing the risk of death or ischemia (Registered by PROSPERO, CRD42020153881).
PMID: 32627616 [PubMed - as supplied by publisher]
Source: Platelets - Category: Hematology Tags: Platelets Source Type: research
More News: Angioplasty | Bleeding | Cardiology | Cardiovascular | Clinical Trials | Coronary Angioplasty | Heart | Heart Attack | Hematology | Ischemic Stroke | Percutaneous Coronary Intervention | Science | Stroke | Thrombosis